IL148242A0 - Polymorphs of n-methyl-n(3-(3-[2 thienylcarbonyl] pyrazol-[1, 5-a]-pyrimidin-7-yl} phenyl) acetamide, pharmaceutical compositions containing the same and processes for the preparation thereof - Google Patents

Polymorphs of n-methyl-n(3-(3-[2 thienylcarbonyl] pyrazol-[1, 5-a]-pyrimidin-7-yl} phenyl) acetamide, pharmaceutical compositions containing the same and processes for the preparation thereof

Info

Publication number
IL148242A0
IL148242A0 IL14824200A IL14824200A IL148242A0 IL 148242 A0 IL148242 A0 IL 148242A0 IL 14824200 A IL14824200 A IL 14824200A IL 14824200 A IL14824200 A IL 14824200A IL 148242 A0 IL148242 A0 IL 148242A0
Authority
IL
Israel
Prior art keywords
thienylcarbonyl
polymorphs
pyrazol
pyrimidin
acetamide
Prior art date
Application number
IL14824200A
Other languages
English (en)
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Publication of IL148242A0 publication Critical patent/IL148242A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL14824200A 1999-09-02 2000-09-01 Polymorphs of n-methyl-n(3-(3-[2 thienylcarbonyl] pyrazol-[1, 5-a]-pyrimidin-7-yl} phenyl) acetamide, pharmaceutical compositions containing the same and processes for the preparation thereof IL148242A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38952499A 1999-09-02 1999-09-02
US42162099A 1999-10-19 1999-10-19
PCT/US2000/024051 WO2001015700A1 (en) 1999-09-02 2000-09-01 POLYMORPHS OF N-METHYL-N-(3-{3-[2-THIENYLCARBONYL]-PYRAZOL-[1,5-α]-PYRIMIDIN -7-YL }PHENYL )ACETAMIDE AND COMPOSITIONS AND METHODS RELATED THERETO

Publications (1)

Publication Number Publication Date
IL148242A0 true IL148242A0 (en) 2002-09-12

Family

ID=27012737

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14824200A IL148242A0 (en) 1999-09-02 2000-09-01 Polymorphs of n-methyl-n(3-(3-[2 thienylcarbonyl] pyrazol-[1, 5-a]-pyrimidin-7-yl} phenyl) acetamide, pharmaceutical compositions containing the same and processes for the preparation thereof
IL148242A IL148242A (en) 1999-09-02 2002-02-19 Polymorphs of n-methyl- n

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL148242A IL148242A (en) 1999-09-02 2002-02-19 Polymorphs of n-methyl- n

Country Status (26)

Country Link
EP (2) EP1477169A1 (pt)
JP (1) JP4592241B2 (pt)
KR (1) KR20020035585A (pt)
CN (2) CN1331865C (pt)
AP (1) AP1631A (pt)
AT (1) ATE269082T1 (pt)
AU (2) AU769856B2 (pt)
BR (1) BR0014459A (pt)
CA (1) CA2382588C (pt)
CZ (1) CZ2002783A3 (pt)
DE (1) DE60011638T2 (pt)
DK (1) DK1214075T3 (pt)
EA (1) EA004706B1 (pt)
ES (1) ES2222920T3 (pt)
HK (1) HK1047407B (pt)
HU (1) HUP0202698A3 (pt)
IL (2) IL148242A0 (pt)
MX (1) MXPA02002314A (pt)
NO (1) NO322752B1 (pt)
NZ (1) NZ517298A (pt)
OA (1) OA12200A (pt)
PL (1) PL353362A1 (pt)
PT (1) PT1214075E (pt)
SK (1) SK2782002A3 (pt)
TR (1) TR200200534T2 (pt)
WO (1) WO2001015700A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003268212B2 (en) * 2002-08-26 2008-08-14 Neurocrine Biosciences, Inc. Novel polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-YL}phenyl)acetamide and compositions and methods related thereto
WO2004110454A1 (ja) * 2003-06-13 2004-12-23 Ishihara Sangyo Kaisha, Ltd. アデノシンA2a受容体アゴニストの投与が必要な疾患を治療又は予防するための組成物
US7371906B2 (en) 2004-08-24 2008-05-13 Eastman Kodak Company Process for photo-oxidative stability improvements
EP1918290A1 (en) 2006-10-11 2008-05-07 Ferrer Internacional, S.A. Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
EP1956021A1 (en) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
CN101177427B (zh) * 2006-11-09 2011-07-20 中国人民解放军军事医学科学院放射与辐射医学研究所 一种用于催眠的化合物的多晶型α和溶剂化物,其制备方法及含该物质的组合物
WO2010109480A2 (en) * 2009-03-24 2010-09-30 Glenmark Generics Limited Processes for the preparation of indiplon and intermediates thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ208554A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions
US4654347A (en) * 1983-06-23 1987-03-31 American Cyanamid Company Aryl and heteroaryl[[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]methanones
US4521422A (en) * 1983-06-23 1985-06-04 American Cyanamid Company Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
DE19975048I2 (de) * 1985-05-13 2001-06-13 American Cyanamid Co 7-(3-Disubstituierte Amino)phenyl pyrazolo 1,5-a -pyrimidine
US5421422A (en) * 1993-11-19 1995-06-06 Boretec Inc Roller cutter mount for tunneling machine

Also Published As

Publication number Publication date
DE60011638D1 (de) 2004-07-22
OA12200A (en) 2006-05-09
EA004706B1 (ru) 2004-06-24
EP1214075B1 (en) 2004-06-16
JP4592241B2 (ja) 2010-12-01
CN1331865C (zh) 2007-08-15
EP1477169A1 (en) 2004-11-17
CA2382588A1 (en) 2001-03-08
HK1047407B (zh) 2004-12-24
AP2002002428A0 (en) 2002-03-31
AU769856B2 (en) 2004-02-05
HUP0202698A3 (en) 2004-12-28
CA2382588C (en) 2008-11-25
AU2004201356A1 (en) 2004-04-29
ES2222920T3 (es) 2005-02-16
EP1214075A1 (en) 2002-06-19
AU6949100A (en) 2001-03-26
HUP0202698A2 (hu) 2002-12-28
NZ517298A (en) 2004-01-30
WO2001015700A9 (en) 2002-09-12
EP1214075A4 (en) 2003-05-02
CZ2002783A3 (cs) 2004-01-14
CN1680376A (zh) 2005-10-12
TR200200534T2 (tr) 2002-06-21
SK2782002A3 (en) 2003-04-01
HK1047407A1 (en) 2003-02-21
WO2001015700A1 (en) 2001-03-08
IL148242A (en) 2006-12-10
PL353362A1 (en) 2003-11-17
AP1631A (en) 2006-07-12
NO322752B1 (no) 2006-12-04
CN1198824C (zh) 2005-04-27
DE60011638T2 (de) 2004-10-21
JP2003508440A (ja) 2003-03-04
ATE269082T1 (de) 2004-07-15
CN1374866A (zh) 2002-10-16
PT1214075E (pt) 2004-11-30
EA200200320A1 (ru) 2002-08-29
DK1214075T3 (da) 2004-10-25
NO20021041D0 (no) 2002-03-01
NO20021041L (no) 2002-04-03
BR0014459A (pt) 2002-07-16
KR20020035585A (ko) 2002-05-11
MXPA02002314A (es) 2002-08-12

Similar Documents

Publication Publication Date Title
HUP0203142A3 (en) Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use
HUP0003844A3 (en) Novel spiroazabicyclic heterocyclic compounds, process for their preparation, their use and pharmaceutical compositions containing them
HUP0203183A3 (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use
HUP0202103A3 (en) 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i]purin-5-one derivatives, their use, pharmaceutical compositions containing them, process for the preparation of the compounds and intermediates
HUP0303148A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing the compounds and processes for their preparation
IL153993A0 (en) Crystalline polymorphs of an epothilone analog, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0203902A3 (en) Substituted oxazolidinones, process for their preparation and pharmaceutical compositions containing them and their use
HUP0204246A3 (en) Novel thiazolo[4,5-d]pyrimidine compounds, process for their preparation, pharmaceutical compositions containing them and their use
HUP0201406A3 (en) Aromatic heterocyclic compounds as antiinflammatory agents, process for their preparation and pharmaceutical compositions containing them
HUP0105108A3 (en) Amide compounds, process for their preparation and pharmaceutical compositions containing them
HUP0402554A3 (en) Condensated heterocyclic succinimide compounds, their use, process for the preparation of some of them and pharmaceutical compositions containing the compounds
HUP9802865A3 (en) N-(substituted phenyl)-pyrazole-derivatives, preparation and use thereof, parasiticidal compositions containing these compounds as active ingredients
HUP9802630A3 (en) Chiral methyl phenyl oxazolidinones, process for their preparation, use thereof and pharmaceutical compositions containing them
AU4143300A (en) Cyclic amide compounds, process for the preparation of the same and uses thereof
IL150392A0 (en) Novel esters derived from (rr, ss)-2-(hydroxbenzoate of 3-(2-dimethylaminomethyl-1-hydroxyclohexyl) phenyl
HUP0401292A3 (en) Pyrazolo[1,5-a]pyridines, pharmaceutical compositions containing the same and process for preparation thereof
HUP0303487A3 (en) Compositions containing 3,7-diazabicyclo [3,3,1] compounds as anthiarhythmic agents and process for preparation of the compounds
HUP0000960A3 (en) Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same
HUP0103751A3 (en) Bile-acid substituted phenyl alkenoyl guanidines, pharmaceutical compositions thereof and process for their preparation
IL148242A0 (en) Polymorphs of n-methyl-n(3-(3-[2 thienylcarbonyl] pyrazol-[1, 5-a]-pyrimidin-7-yl} phenyl) acetamide, pharmaceutical compositions containing the same and processes for the preparation thereof
HUP0402253A3 (en) Process for the purification of n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)-phenyl]-n-ethylacetamide(zaleplon) and the preparation of its novel crystalline forms and pharmaceutical compositions containing the latters
HUP0001093A3 (en) Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation
HUP0002159A3 (en) Process for preparing intermediates of pesticidally active compounds, the novel intermediates using in this process and preparation thereof
IL140414A0 (en) Beta lactam compounds, processes for the preparation thereof and pharmaceutical compositions containing the same
PL350232A1 (en) Controlled-release compositions of betahistine

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed